| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/27/2001 | EP1109931A1 METHOD FOR STUDYING PROTEIN INTERACTIONS $i(IN VIVO) |
| 06/27/2001 | EP1109930A1 Luciferase assay, compositions and kits for use in connection therewith |
| 06/27/2001 | EP1109925A1 Recombinant adenovirus for tissue specific expression in heart |
| 06/27/2001 | EP1109920A1 Fusion proteins, dna molecules, vectors, and host cells useful for measuring protease activity |
| 06/27/2001 | EP1109919A2 Rationally designed heparinases derived from heparinase i and ii |
| 06/27/2001 | EP1109918A2 Polypeptides, polynucleotides and uses thereof |
| 06/27/2001 | EP1109917A2 Human transferase proteins |
| 06/27/2001 | EP1109915A1 Nucleotide sequences for the tal gene |
| 06/27/2001 | EP1109913A1 Nucleotide sequences which code for the opca gene |
| 06/27/2001 | EP1109911A2 Staphylococcus aureus genes and polypeptides |
| 06/27/2001 | EP1109908A2 Leptin induced genes |
| 06/27/2001 | EP1109907A1 Human cell junction pdz protein |
| 06/27/2001 | EP1109906A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
| 06/27/2001 | EP1109905A1 Genes encoding for the human and murine death inducer-obliterator-1 |
| 06/27/2001 | EP1109904A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof |
| 06/27/2001 | EP1109903A2 Human rna-associated proteins |
| 06/27/2001 | EP1109899A1 Product and method for separation of a sample containing multiple sources of genetic material using a solid medium |
| 06/27/2001 | EP1109833A2 Compositions and methods for the treatment of tumors |
| 06/27/2001 | EP1109830A1 Mc4-r as target for the identification of compounds used to treat drug addiction |
| 06/27/2001 | EP1109829A1 Human latent transforming growth factor beta binding protein 3 |
| 06/27/2001 | EP1109828A1 Peptide fragments of cholera toxin b or enterotoxin b as vaccine adjuvants |
| 06/27/2001 | EP1109824A1 Novel bag proteins and nucleic acid molecules encoding them |
| 06/27/2001 | EP1109823A1 Modifications of the vegf receptor-2 protein and methods of use |
| 06/27/2001 | EP1109821A1 49 human secreted proteins |
| 06/27/2001 | EP1109805A1 Inhibitors of bacterial nad synthetase |
| 06/27/2001 | EP1109567A1 Drug screening and diagnosis based on paracrine tubular renin-angiotensin system |
| 06/27/2001 | EP1109566A1 Gcp |
| 06/27/2001 | EP1109492A2 Device and method for preparing and preserving a personal cell bank, especially for genetic analyses involving dna analyses |
| 06/27/2001 | EP1046717A9 Method and probes for determining a concentration of target nucleic acid molecules and method for analyzing data obtained by the method |
| 06/27/2001 | EP0725800B1 cDNA ENCODING A NOVEL HUMAN PROTEIN TYROSINE PHOSPHATASE |
| 06/27/2001 | EP0724646B1 Dna sequences related to isolated fragile x syndrome |
| 06/27/2001 | EP0695421B1 Method of measuring chemiluminescence of multiple samples on a continuous matrix |
| 06/27/2001 | EP0629131B1 Antigens protective against (echinococcus granulosus) infection and vaccines containing such antigens |
| 06/27/2001 | CN2436510Y Biological chip |
| 06/27/2001 | CN1301343A Biosensor comprising a lipid membrane containing gated ion channels |
| 06/27/2001 | CN1301341A Device and method for obtaining and initially preparing tissue samples for molecular genetic diagnosis |
| 06/27/2001 | CN1301311A Detection of DNA, RNA and proteins |
| 06/27/2001 | CN1301302A Gene encoding labyrinthin, a marker for cancer |
| 06/27/2001 | CN1301296A Disposable apparatus for determining antibiotic sensitivity of bacteria |
| 06/27/2001 | CN1301180A Recombinant i(mycoplasma hyopneumoniae) vaccine |
| 06/27/2001 | CN1301166A Steroidal saponins for treating alzheimer's disease |
| 06/27/2001 | CN1300941A Nucleic acid probe and its usage |
| 06/27/2001 | CN1300856A Individual gene databank |
| 06/27/2001 | CN1300855A Bacterial ribosome ribonucleic acid amplification in vitro-gene chip |
| 06/27/2001 | CN1300851A Pinellia agglutinin protein and its coding sequence |
| 06/27/2001 | CN1300837A Polypeptide-hydroxymethyl glutaryl A reductase 9 and polynucleotide for coding this polypeptide |
| 06/27/2001 | CN1067550C Calcium receptor active molecules |
| 06/26/2001 | US6252130 Production of somatic mosaicism in mammals using a recombinatorial substrate |
| 06/26/2001 | US6252059 Oligonucleotides; for the detection and counting of preferential viral nucleic acids |
| 06/26/2001 | US6252050 Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method |
| 06/26/2001 | US6252047 Polypeptide associated with the diagnosis, treatment and prevention of cancer; antitumor agents |
| 06/26/2001 | US6252043 Fusion protein for the treatment of inflammation; for the detection and prevention of leukocyte adhesion to endothelial cells |
| 06/26/2001 | US6252042 Reacting peptide and protein with complex |
| 06/26/2001 | US6251955 Culturing mutant fungal strains; claibration |
| 06/26/2001 | US6251871 Administering pharmaceutical composition comprising adenoviral vector comprising promoter functional in eukaryotic cells and nucleic acid encoding p16 and buffer, solvent or diluent to mammal to inhibit tumor growth |
| 06/26/2001 | US6251853 Pertussis toxin (ptx); beta-3 subunit of human g protein with not more than six wd repeat motifs; for the diagnosis of disorders, such as a disease associated with g protein dysregulation (i.e. hypertension) |
| 06/26/2001 | US6251691 Monitoring migration of particles suspended at an interface between an electrode and an electrolyte solution; generate electric potential, illuminate the surface, monitor movement of particles |
| 06/26/2001 | US6251684 Uniform beads |
| 06/26/2001 | US6251682 Method and markers for prognosticating efficacy of anticancer agents |
| 06/26/2001 | US6251676 Mammalian cell two-hybrid system |
| 06/26/2001 | US6251674 Evolution of whole cells and organisms by recursive sequence recombination |
| 06/26/2001 | US6251669 Mammalian, non-tumor derived cells which divide, express neuron-specific markers, and give rise to progeny which differentiate into neuronal cells; for transplantation in treatment of alzheimer's/parkinson's diseases |
| 06/26/2001 | US6251666 Ribozyme with at least one l-nucleotide substitution; nuclease resistance |
| 06/26/2001 | US6251664 Human gene sequence of the down syndrome critical region of human chromosome 21, coding for a serine-threonine protein kinase (MNB), expressed in the neuronal regions affected in down syndrome |
| 06/26/2001 | US6251661 Seamless capsule for synthesizing biopolymer and method for producing the same |
| 06/26/2001 | US6251660 Devices and methods for detecting target molecules in biological samples |
| 06/26/2001 | US6251659 Biological sample treating apparatus |
| 06/26/2001 | US6251652 Amino acid sequence from staphylococcus cystathionine gamma-lyase gene; drug screening; bactericides; bacteriostats; vaccines; antibodies |
| 06/26/2001 | US6251645 Leflunomide-resistant helicase; anticarcinogenic agents; antidiabetic agents; immunosuppressants; treatment of alzheimer's disease, atherosclerosis, osteoporosis, autoimmune disorders, and rheumatoid arthritis |
| 06/26/2001 | US6251639 Methods and compositions for linear isothermal amplification of polynucleotide sequences, using a RNA-DNA composite primer |
| 06/26/2001 | US6251638 Noninvasive analysis of fetal dna that has crossed placental and kidney barriers; sex determination; diagnosis of disease |
| 06/26/2001 | US6251637 Cycle sequencing of dna using dideoxynucleotides labeled with marker dye usable at or near optimum chain elongation temperature and on gc-rich sequences |
| 06/26/2001 | US6251630 Polynucleotide encoding member of ribonuclease family of defined amino acid sequence; diagnosis; bacteriostats; bactericides; vaccines; treatment of otitis media, pneumonia, conjunctivitis, bacteremia, meningitis, sinusitis, and others |
| 06/26/2001 | US6251628 Isolated nucleic acid molecules encoding Smad7 |
| 06/26/2001 | US6251624 Apparatus and method for detecting, quantifying and characterizing microorganisms |
| 06/26/2001 | US6251623 Quick assay method for the activity of a plant-derived, asparagine residue-specific endoprotease |
| 06/26/2001 | US6251622 Treating or preventing leukocyte-mediated injury or inflammatory response by administering farnesyl dipohsphate, presqualene diphosphate, farnesyl monophosphate, presqualene monophosphate or presqualene diphosphate analog |
| 06/26/2001 | US6251621 Rapid, accurate, cost effective, simple method by placing sample in device so that it contacts first solid support with immobilized reporter enzyme, reaction of protease frees reporter enzyme to contact indicator on other solid support |
| 06/26/2001 | US6251617 Screening for modulators of glycine transport; incubate cells with modulator and measure amount of glycine transport activity |
| 06/26/2001 | US6251614 Rapid methods for identifying modifiers of cellular apoptosis activity |
| 06/26/2001 | US6251613 Method for detecting anti-GADII antibody and method for diagnosing cancer using said detection method |
| 06/26/2001 | US6251610 Generating single stranded sequences from deoxyribonucleic acids; amplify deoxyribonucleic acids, denature amplified nucleic acids, hybridize with single stranded nucleic acids, elongate single stranded sequence and denature products |
| 06/26/2001 | US6251609 Nucleotide sequences for detection of microorganismal infection |
| 06/26/2001 | US6251608 Method of determining a potential of a hyperglycemic patients of developing vascular complications |
| 06/26/2001 | US6251607 Preferential nucleotide sequences for screening for the presence of preferential microorganism in feces and food |
| 06/26/2001 | US6251606 Gene sequence and method for distinguishing cordyceps sinensis |
| 06/26/2001 | US6251603 Evaluating cancer in humans; detect preferential gene expression in tumor, mix sample with antibodies which bind preferential protein, count amount of protein, an amplified protein value indicates adjustment in cancer classification |
| 06/26/2001 | US6251602 Cell systems having specific interaction of peptide binding pairs |
| 06/26/2001 | US6251601 Simultaneous measurement of gene expression and genomic abnormalities using nucleic acid microarrays |
| 06/26/2001 | US6251600 Amplification of target nucleotide sequence; mix nucleotide sequences and probes, incubate with splitting enzyme, count and classify the amount of probe release |
| 06/26/2001 | US6251598 Methods for diagnosing sepsis |
| 06/26/2001 | US6251596 Aspergillus N-myristoyl transferase genes and polyeptides and uses thereof |
| 06/26/2001 | US6251594 Cancer diagnostic method based upon DNA methylation differences |
| 06/26/2001 | US6251593 Regulatory sequences which are induced by maltose; for use in development of fungicides; for use in control of cell propagation |
| 06/26/2001 | US6251592 Nucleotide sequence duplications used for the determination of heredity in humans |
| 06/26/2001 | US6251591 Quantitative method for detecting nucleotide concentration |
| 06/26/2001 | US6251590 Differential Qualitative screening |
| 06/26/2001 | US6251589 Diagnosing genetic disorder of brain and central nervous system; amplify nucleotide sequences, recover products, detect duplications, the presence of a preferential number of duplications is indicative of genetic disorder |
| 06/26/2001 | US6251588 Monitoring preferential nucleotide hybridization to target nucleotide sequence; generate nucleotide sequence of preferential size, incubate with target nucleotide sequences and monitor hybridization |
| 06/26/2001 | US6251587 Evaluating humans diagnosed with nervous system disorders; diagnose human with defect, determine genotype or phenotype of human, classify nervous system disorders |